» Articles » PMID: 38106475

Association Between Gut Microbiota and NAFLD/NASH: a Bidirectional Two-sample Mendelian Randomization Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent studies have suggested a relationship between gut microbiota and non-alcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH). However, the nature and direction of this potential causal relationship are still unclear. This study used two-sample Mendelian randomization (MR) to clarify the potential causal links.

Methods: Summary-level Genome-Wide Association Studies (GWAS) statistical data for gut microbiota and NAFLD/NASH were obtained from MiBioGen and FinnGen respectively. The MR analyses were performed mainly using the inverse-variance weighted (IVW) method, with sensitivity analyses conducted to verify the robustness. Additionally, reverse MR analyses were performed to examine any potential reverse causal associations.

Results: Our analysis, primarily based on the IVW method, strongly supports the existence of causal relationships between four microbial taxa and NAFLD, and four taxa with NASH. Specifically, associations were observed between Enterobacteriales ( =0.04), ( =0.04), ( =0.02), and ( =0.04) and increased risk of NAFLD. ( =0.03) and ( =0.04) could increase the risks of NASH while ( =0.04) and (=0.005) could decrease them. We also identified that NAFLD was found to potentially cause an increased abundance in ( =0.007) and ( =0.002). However, we found no evidence of reverse causation in the microbial taxa associations with NASH.

Conclusion: This study identified several specific gut microbiota that are causally related to NAFLD and NASH. Observations herein may provide promising theoretical groundwork for potential prevention and treatment strategies for NAFLD and its progression to NASH in future.

Citing Articles

Metabolites mediate the causal associations between gut microbiota and NAFLD: a Mendelian randomization study.

Ouyang C, Liu P, Liu Y, Lan J, Liu Q BMC Gastroenterol. 2024; 24(1):244.

PMID: 39085775 PMC: 11292861. DOI: 10.1186/s12876-024-03277-w.


Identification of m6A-associated autophagy genes in non-alcoholic fatty liver.

Huang Z, Luo L, Wu Z, Xiao Z, Wen Z PeerJ. 2024; 12:e17011.

PMID: 38436022 PMC: 10909346. DOI: 10.7717/peerj.17011.

References
1.
Zeng Y, Cao S, Yang H . Roles of gut microbiome in epilepsy risk: A Mendelian randomization study. Front Microbiol. 2023; 14:1115014. PMC: 10010438. DOI: 10.3389/fmicb.2023.1115014. View

2.
DuPont A, DuPont H . The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol. 2011; 8(9):523-31. DOI: 10.1038/nrgastro.2011.133. View

3.
Leclercq S, Matamoros S, Cani P, Neyrinck A, Jamar F, Starkel P . Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A. 2014; 111(42):E4485-93. PMC: 4210345. DOI: 10.1073/pnas.1415174111. View

4.
Richmond R, Davey Smith G . Mendelian Randomization: Concepts and Scope. Cold Spring Harb Perspect Med. 2021; 12(1). PMC: 8725623. DOI: 10.1101/cshperspect.a040501. View

5.
Skelly A, Sato Y, Kearney S, Honda K . Mining the microbiota for microbial and metabolite-based immunotherapies. Nat Rev Immunol. 2019; 19(5):305-323. DOI: 10.1038/s41577-019-0144-5. View